Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared a post on X:
“Calm before the storm? Exhilarating discussions with the Scientific Chair of ASCO25 Erika Hamilton as the pre-view meeting kicks off in the music city before we head off to Chicago ! Momentum is building. Let’s go ASCO25!”
More posts featuring ASCO 2025.
